The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Systemic Inflammatory Parameters in Patients With Atherosclerosis of the Coronary and Peripheral Arteries
Abstract
Abstract —Plasma concentration of markers of inflammation are increased in patients with atherosclerosis. However, it is unclear whether the pattern and magnitude of this increase vary with the site and extent of disease. In 147 patients undergoing semiquantitative coronary angiography, we measured the acute-phase reactants C-reactive protein (CRP) or serum amyloid A (SAA); the proinflammatory cytokine interleukin 6 (IL-6); the active and total fractions of the anti-inflammatory cytokine transforming growth factor-β (TGF-β); the macrophage activation marker neopterin; and the infection marker procalcitonin. Compared with 62 patients without either coronary artery disease (CAD) or peripheral artery disease (PAD), 57 patients with CAD but no PAD showed greater median CRP (0.4 versus 0.2 mg/dL, P =0.004) and IL-6 (3.8 versus 1.6 pg/mL, P =0.007) levels and a lower level of active-TGF-β (57 versus 100 ng/mL, P =0.038). Moreover, CRP, IL-6, and neopterin levels showed a positive and the active TGF-β level a negative correlation with the extent of coronary atherosclerosis. Compared with these 57 patients with CAD alone, 15 patients with PAD and CAD had higher median levels of SAA (17 versus 7 mg/mL, P =0.008), IL-6 (12 versus 4 pg/mL, P =0.002), neopterin (14 versus 11 mg/dL, P =0.006), and total TGF-β (11834 versus 6417 ng/L, P =0.001). However, these strong univariate associations of markers of inflammation and atherosclerosis were lost in multivariate analysis once age, sex, and high density lipoprotein cholesterol or fibrinogen were taken into account. Increased plasma levels of CRP, SAA, IL-6, TGF-β, neopterin, and procalcitonin constitute an inflammatory signature of advanced atherosclerosis and are correlated with the extent of disease but do not provide discriminatory diagnostic power over and above established risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor
Trinder, P. (1969) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/000456326900600108 · Cited by 4,615
Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (1957) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,208
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,357
High serum procalcitonin concentrations in patients with sepsis and infection
Assicot, M., Bohuon, C., Gendrel, D., Raymond, J., Carsin, H., & Guilbaud, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90277-n · Cited by 2,197
Meade, T. W., Brozovic, M., Chakrabarti, R. R., Haines, A. P., Imeson, J. D., Mellows, S., Miller, G. J., North, W. R. S., Stirling, Y., & Thompson, S. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90111-x · Cited by 1,939
Van Snick, J. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.001345 · Cited by 1,890
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., & Tibblin, G. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110804 · Cited by 1,646
Pepys, M. B., & Baltz, M. L. (1983) · Advances in Immunology · doi:10.1016/s0065-2776(08)60379-x · Cited by 1,272
Huber, C., Batchelor, J. R., Fuchs, D., Hausen, A., Lang, A., Niederwieser, D., Reibnegger, G., Swetly, P., Troppmair, J., & Wachter, H. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.1.310 · Cited by 1,084
Plasma Concentration of C-Reactive Protein and Risk of Developing Peripheral Vascular Disease
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.97.5.425 · Cited by 975
TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights
Moses, H. L., Yang, E. Y., & Pietenpol, J. A. (1990) · Cell · doi:10.1016/0092-8674(90)90155-8 · Cited by 959
Fibrinogen and Risk of Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.1987.03400090067035 · Cited by 886
Battegay, E. J., Raines, E. W., Seifert, R. A., Bowen-Pope, D. F., & Ross, R. (1990) · Cell · doi:10.1016/0092-8674(90)90448-n · Cited by 741
Enzymatische Bestimmung des Gesamt-Cholesterins im Serum
Röschlau, P., Bernt, E., & Gruber, W. (1974) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.1974.12.9.403 · Cited by 733
The Pathogenesis of Atherosclerosis: Atherogenesis and Inflammation
Munro, J. M., & Cotran, R. S. (1989) · Pathology Reviews · 1989 · doi:10.1007/978-1-4612-4502-5_10 · Cited by 698
Gown, A. M., Tsukada, T., & Ross, R. (1986) · PubMed · Cited by 676
Cholesterol and Mortality: 30 Years of Follow-up From the Framingham Study
Anderson, K. M. (1987) · JAMA · doi:10.1001/jama.1987.03390160062027 · Cited by 620
Sur un dosage rapide du cholesterol lié aux α-et aux β-lipoprotéines du sérum
Burstein, M., & Samaille, J. (1960) · Clinica Chimica Acta · doi:10.1016/0009-8981(60)90075-9 · Cited by 620
Elevation of C-reactive protein in “active” coronary artery disease
Berk, B. C., Weintraub, W. S., & Alexander, R. W. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90079-g · Cited by 588
Kannel, W. B., D'Agostino, R. B., & Belanger, A. J. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90063-9 · Cited by 467
Miettinen, H., Lehto, S., Saikku, P., Haffner, S. M., Ronnemaa, T., Pyorala, K., & Laakso, M. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014934 · Cited by 447
Inflammation and Coronary Artery Disease
Alexander, R. W. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310709 · Cited by 400
Is atherosclerosis an immunologically mediated disease?
Wick, G., Schett, G., Amberger, A., Kleindienst, R., & Xu, Q. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80067-0 · Cited by 398
Grainger, D. J., Kemp, P. R., Metcalfe, J. C., Liu, A. C., Lawn, R. M., Williams, N. R., Grace, A. A., Schofield, P. M., & Chauhan, A. (1995) · Nature Medicine · doi:10.1038/nm0195-74 · Cited by 378
Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall
Rus, H. G., Vlaicu, R., & Niculescu, F. (1996) · Atherosclerosis · doi:10.1016/s0021-9150(96)05968-0 · Cited by 335
The Münster Heart Study (PROCAM). Results of follow-up at 8 years.
Assmann, G., Cullen, P., & Schulte, H. (1998) · PubMed · Cited by 332
Self-citationChiu, B., Viira, E., Tucker, W., & Fong, I. W. (1997) · Circulation · doi:10.1161/01.cir.96.7.2144 · Cited by 307
Isolation of Chlamydia pneumoniae from a Carotid Endarterectomy Specimen
Jackson, L. A., Campbell, L. A., Kuo, C., Rodriguez, D. I., Lee, A., & Grayston, J. T. (1997) · The Journal of Infectious Diseases · doi:10.1086/517270 · Cited by 293
Sullivan, D. R., Marwick, T. H., & Freedman, S. B. (1990) · American Heart Journal · doi:10.1016/s0002-8703(05)80173-5 · Cited by 276
Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions
Seino, Y., Ikeda, U., Ikeda, M., Yamamoto, K., Misawa, Y., Hasegawa, T., Kano, S., & Shimada, K. (1994) · Cytokine · doi:10.1016/1043-4666(94)90013-2 · Cited by 263
Wiseman, D. M., Polverini, P. J., Kamp, D. W., & Leibovich, S. J. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80319-x · Cited by 232
Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms
Juvonen, J., Juvonen, T., Laurila, A., Alakärppä, H., Lounatmaa, K., Surcel, H.-M., Leinonen, M., Kairaluoma, M. I., & Saikku, P. (1997) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(97)70260-x · Cited by 205
Aviram, M. (1996) · PubMed · Cited by 203
Heinrich, J., Schulte, H., Schönfeld, R., Köhler, E., & Assmann, G. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1653783 · Cited by 200
Self-citationCytomegalovirus DNA in arterial walls of patients with atherosclerosis
Melnick, J. L., Hu, C., Burek, J., Adam, E., & Debakey, M. E. (1994) · Journal of Medical Virology · doi:10.1002/jmv.1890420213 · Cited by 189
C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas.
Gd, R., & Vance, R. P. (1987) · PubMed · Cited by 182
C‐reactive protein levels as a direct indicator of interleukin‐6 levels in humans in vivo
Bataille, R., & Klein, B. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350824 · Cited by 162
Szekanecz, Z., Shah, M. R., Pearce, W. H., & Koch, A. E. (1994) · Inflammation Research · doi:10.1007/bf01983484 · Cited by 161
Kishikawa, H., Shimokama, T., & Watanabe, T. (1993) · Virchows Archiv A Pathological Anatomy and Histopathology · doi:10.1007/bf01606532 · Cited by 158
Immunoglobulins and complement components in human aortic atherosclerotic intima
Vlaicu, R., Rus, H., Niculescu, F. I., & Cristea, A. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90164-9 · Cited by 148
Elevated serum neopterin levels in atherosclerosis
Tatzber, F., Rabl, H., Koriska, K., Erhart, U., Puhl, H., Waeg, G., Krebs, A., & Esterbauer, H. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90061-7 · Cited by 138
Kropf, J., Schurek, J. O., Wollner, A., & Gressner, A. M. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.10.1965 · Cited by 138
Self-citationFyfe, A. I., Rothenberg, L. S., deBeer, F. C., Cantor, R. M., Rotter, J. I., & Lusis, A. J. (1997) · Circulation · doi:10.1161/01.cir.96.9.2914 · Cited by 135
Increased concentrations of neopterin in carotid atherosclerosis
Weiß, G., Willeit, J., Kiechl, S. J., Fuchs, D., Jarosch, E., Oberhollenzer, F., Reibnegger, G. J., Tilz, M. G. P., Gerstenbrand, F., & WACHTER, H. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90131-7 · Cited by 134
Mitchinson, M. J., & Ball, R. Y. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92341-5 · Cited by 131
Kröpf, J., Schurek, J. O., Wollner, A., & Gressner, A. M. (1997) · PubMed · Cited by 122
Self-citationNiculescu, F. I., Rus, H., & Vlaicu, R. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90002-5 · Cited by 115
Budde, T., Fechtrup, C., Bösenberg, E., Vielhauer, C., Enbergs, A., Schulte, H., Assmann, G., & Breithardt, G. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.11.1730 · Cited by 103
Self-citationCirculating transforming growth factor β1 and coronary artery disease
Wang, X., Liu, S. X., & Wilcken, D. E. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00033-3 · Cited by 100
Katsuda, S., Coltrera, M. D., Ross, R., & Gown, A. M. (1993) · PubMed · Cited by 92
Active and acid-activatable TGF-β in human sera, platelets and plasma
Grainger, D. J., Mosedale, D. E., Metcalfe, J. C., Weissberg, P. L., & Kemp, P. R. (1995) · Clinica Chimica Acta · doi:10.1016/0009-8981(94)05995-4 · Cited by 91
Hatanaka, K., Li, X., Masuda, K., et al. (1995) · Pathology International · doi:10.1111/j.1440-1827.1995.tb03515.x · Cited by 68
Predictors of the presence and extent of peripheral arterial occlusive disease.
Drexel, H., Steurer, J., Muntwyler, J., Meienberg, S., Hr, S., Schneider, E., Gröchenig, E., & Fw, A. (1996) · PubMed · Cited by 59
Constitutive and NF-κB—like proteins in the regulation of the serum amyloid a gene by interleukin 1
Edbrooke, M. R., Földi, J., Cheshire, J. K., Li, F., Faulkes, D. J., & Woo, P. M. (1991) · Cytokine · doi:10.1016/1043-4666(91)90041-b · Cited by 58
Interleukin-6 Causes Hypocholesterolemia in Middle-aged and Old Rhesus Monkeys
Ettinger, W. H., Sun, W. H., Binkley, N., Kouba, E. O., & Ershler, W. B. (1995) · The Journals of Gerontology Series A · doi:10.1093/gerona/50a.3.m137 · Cited by 45
Assmann, G., Cullen, P., Heinrich, J., & Schulte, H. (1996) · PubMed · Cited by 43
Self-citationAndalibi, A., Liao, F., Imes, S., Fogelman, A. M., & Lusis, A. J. (1993) · Biochemical Society Transactions · doi:10.1042/bst0210651 · Cited by 40
Proliferation of human aortic vascular smooth muscle cells in culture is modulated by active TGF
Kirschenlohr, H. L., Metcalfe, J. C., Weissberg, P. L., & Grainger, D. J. (1995) · Cardiovascular Research · doi:10.1016/s0008-6363(96)88622-6 · Cited by 37
Transcription and translation are required for fibrinogen mRNA degradation in hepatocytes
Nesbitt, J. E., & Fuller, G. M. (1991) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(91)90089-5 · Cited by 24
Inflammation and Coronary Heart Disease
Marton, K. (2000) · Journal watch · doi:10.1056/jw200008290000001 · Cited by 19
Cited by
Visser, M., Pahor, M., Taaffe, D. R., Goodpaster, B. H., Simonsick, E. M., Newman, A. B., Nevitt, M., & Harris, T. B. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.5.m326 · Cited by 1,294
Inflammatory markers and loss of muscle mass (sarcopenia) and strength
Schaap, L. A., Pluijm, S. M. F., Deeg, D. J. H., & Visser, M. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.049 · Cited by 1,047
von Eckardstein, A., Nofer, J.-R., & Assmann, G. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.1.13 · Cited by 695
Self-citationSchaap, L. A., Pluijm, S. M. F., Deeg, D. J. H., Harris, T. B., Kritchevsky, S. B., Newman, A. B., Colbert, L. H., Pahor, M., Rubin, S. M., Tylavsky, F. A., et al. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glp097 · Cited by 683
HDL and arteriosclerosis: beyond reverse cholesterol transport
Nofer, J.-R., Kehrel, B., Fobker, M., Levkau, B., Assmann, G., & Eckardstein, A. V. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00651-7 · Cited by 595
Self-citation
Metadata
- Authors
- Erren, M., Reinecke, H., Junker, R., Fobker, M., Schulte, H., Schurek, J. O., Kropf, J., Kerber, S., Breithardt, G., Assmann, G., & Cullen, P.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1999-10
- Volume
- 19
- Issue
- 10
- Pages
- 2355-2363
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2166920740
- Cited by
- 306
- References
- 63
- FWCI
- 3.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.